Status:
WITHDRAWN
Medication in Early Diabetes (MED) Study
Lead Sponsor:
Menzies School of Health Research
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
This study compares metformin (current first-line medication) to pioglitazone (a newer diabetic medication currently approved for combination use). Whilst there is good evidence for the benefits of pi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Drug naïve Indigenous Australians with Type 2 Diabetes
- Permanent resident of Darwin for at least 1 year immediately before and expected to be for at least 1 year after study commences
- Participants must be able to give informed voluntary consent
- Both males and females (females of child bearing potential excluded if not on reliable means of contraception)
Exclusion
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00437970
Start Date
April 1 2008
End Date
February 1 2009
Last Update
May 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menzies School of Health Research
Darwin, Northern Territory, Australia, 0810